TELA TELA Bio Market Cap to Net Assets Ratio
The TELA Bio, Inc. (TELA) price chart demonstrates the dynamics of a company profiting from the creation of advanced bio-transplants, where OviTex tissues for plastic surgery serve as the primary profit generator. Revenues are based on wholesale supplies of bioengineered meshes to clinics and surgical centers to ensure tissue healing. Production is automated on modern lines, and current process efficiency stands at -2.77.
TELA (TELA Bio, Inc.): analytical breakdowns and indicator data
For TELA Bio, Inc. (TELA), this indicator determines the market revaluation of the company's net assets. By analyzing the price-to-book ratio chart, an investor can identify the premium over the equity value. This metric compares current market capitalization with the book value of the business. The high premium is justified by the integration of OviTex biomatrices into surgical protocols. The creation of switching costs increases the company's fundamental value.